Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px
Document › Details

Novimmune S.A.. (9/19/16). "Press Release: Novimmune Broadens Senior Management Team".

Organisations Organisation Novimmune S.A.
  Organisation 2 Auris Medical AG
  Group Auris Medical (Group)
Products Product therapeutic antibody
  Product 2 drug development
Persons Person Zimmermann, Sven (Novimmune 201609– CFO before Auris Medical + PregLem + UBS Investment Bank)
  Person 2 Fleurant, Mylène (Novimmune 201609– Global Head of Quality before Alvotech + Novartis Pharma + Merck Serono)
     


Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs, announced today two new appointments to its Senior Management Team, Chief Financial Officer (CFO) Sven Zimmermann, and Global Head of Quality Mylène Fleurant.

“We continue to add capabilities to our strong and experienced management team to support our growth strategy. With their wealth of professional experience, these two new colleagues will help us to advance Novimmune to the next level as we move closer to the market with our lead program, NI-0501, which is being developed for the rare disease Hemophagocitic Lymphohistiocytosis,” said Novimmune Chairman and Chief Executive Officer, Eduard Holdener.

Sven Zimmermann brings to Novimmune over 15 years of both scientific and business experience in the biopharma industry. He was involved in a number of finance transactions in both private and public equity markets including IPOs, fund raisings, and M&A transactions. Sven previously held the position of CFO at Auris Medical AG (IPO on NASDAQ) and PregLem SA (acquired by Gedeon Richter Plc.). Prior to that, Sven was European Biotech analyst at UBS Investment Bank. He also served as the chairman of Aimago SA (acquired by Novadaq Technologies Inc.) and is a board member of Epiontis GmbH. Sven holds a PhD in Molecular Biology from the University of Zurich.

Mylène Fleurant spent 20 years of her career in Quality in life sciences. Before joining Novimmune, Mylène was Head of Quality Affairs at Alvotech. Prior to Alvotech, she spent 10 years in leading the supply chain quality at affiliates covering clinical to commercial activities as Region Head Quality Assurance (QA) Europe for Novartis Pharma and implementing Global Quality Systems at Merck Serono. In addition, she spent ten years in various roles in QA Validation and Audits in Pharma and Biotech industries in Canada. Mylène is a Professional Chemical Engineer and holds a Master Degree in Engineering Project Management from the University of Sherbrooke, Canada. She holds a Quality Assurance Management degree from L'École de Technologie Supérieure (ETS), University of Quebec.


Contact:

Adrian Mills
Telephone: +41 22 593 51 40
amills@novimmune.com

   
Record changed: 2016-12-12

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Novimmune S.A.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px




» top